Fri, Aug 21 05:42 AM

Nektar Therapeutics chief R&D officer Zalevsky sells $13,388 in shares

Investing.com•Fri, Aug 21, 2026, 05:16 AM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/insider-trading-news/nektar-therapeutics-chief-rd-officer-zalevsky-sells-13388-in-shares-93CH-4870838)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #nektar #therapeutics #chief #officer #zalevsky #sells #shares

More Headlines

FinanceSeeking Alpha• 7m ago

Columbia Small Cap Value And Inflection Fund Q2 2026 Commentary

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 11m ago

CoreWeave CEO Michael Intrator sells $29.5m in stock

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 11m ago

Arthur J. Gallagher VP Mead sells $899k in company stock

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 12m ago

Will AI Become The Great Equaliser?

Developing story — details emerging. Check the source link for the latest updates.

FinanceBloomberg Markets• 13m ago

Monte Paschi Offers to Buy BPM, Banca Generali for €34 Billion

Banca Monte dei Paschi di Siena SpA is seeking to buy two separate banks for a combined value of €34 billion ($40 billion) as it seeks to prevent being bought by rival Intesa Sanpaolo SpA.

FinanceInvesting.com• 14m ago

Bessent says U.S. to impose ‘toughest sanctions in history’ on Iran

Developing story — details emerging. Check the source link for the latest updates.